Company intelligence / Profile preview

CareMed Specialty Pharmacy

New Hyde Park, New York, United States

Ownership: Private
Employees: ~85
Development stage: Other

Overview

CareMed is a specialty pharmacy provider licensed in all 50 states, dedicated to rare, orphan, and complex disease management. The company has been selected as a national specialty pharmacy partner for Leqembi (lecanemab-irmb), an FDA-approved Alzheimer's disease treatment.

Therapeutic areas: ImmunologyNephrologyEndocrinologyCardiovascularNeurologyDermatologyInfectious DiseasesPulmonologyRare DiseasesRheumatologyOncology
Industry: Non-Academic Healthcare

Partnerships

Eisai (Leqembi distribution partnership)

Beyond the preview

Go deeper on CareMed Specialty Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CareMed Specialty Pharmacy.

Explore the full profile